3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Head & Neck
285
Gastrointestinal
34
Genitourinary
29
Gynecologic
28
Thoracic
20
Other hematologic neoplasm
9
Breast
9
Dermatologic
8
Sarcoma
4
Other
4
Lymphoid
4
Other neoplasm
3
CNS
3
Plasma cell
2
Myeloid
2
Other solid neoplasm
1
Endocrine
1
Conditions
Advanced Solid Tumors
481
Solid Tumor
418
Advanced Solid Tumor
409
Unspecified Adult Solid Tumor, Protocol Specific
350
Solid Tumors
322
Mesothelioma, Malignant
281
Mesothelioma
244
Solid Tumor, Adult
113
Carcinoma, Non-Small-Cell Lung
109
Retinoblastoma
81
Ovarian Neoplasms
65
Lung Neoplasms
61
Melanoma
56
Sarcoma
52
Stomach Neoplasms
50
Carcinoma, Renal Cell
49
Colorectal Neoplasms
46
Small Cell Lung Carcinoma
45
Pancreatic Neoplasms
45
Esophageal Neoplasms
45
Neoplasms
43
Uterine Cervical Neoplasms
41
Breast Neoplasms
38
Advanced or Metastatic Solid Tumors
35
Hematopoietic and Lymphatic System Neoplasm
34
Neoplasm Metastasis
33
Squamous Cell Carcinoma of Head and Neck
32
Advanced Malignant Solid Tumors
31
Solid Tumours
30
Triple Negative Breast Neoplasms
29
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Oropharyngeal Neoplasms
×
Other solid neoplasm
×
Clear all
NCT04301011
2025-04-23
RAPTOR
Turnstone Biologics, Corp.
Phase 1
Terminated
27 enrolled